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Background:  Recent data have suggested a valuable role of peripheral blood gene expression for the detection of coronary artery disease (CAD) 
in patients with intermediate risk. Receiver-operating characteristic analysis of a classifier score ( Cardiodx- “Corus score”) by real-time polymerase 
chain reaction has been designed for this approach. A score of 32 is suggestive of an approximately 60% likelihood for development of CAD. Patients 
with established CAD have been generally excluded from reported analyses. We therefore sought to determine the Corus score (CS) in patients with 
established CAD and to compare it with those with no CAD.
Method: 108 patients in a cardiology practice underwent measurement of their CS. They were divided into 3 groups based on presence of CAD and 
symptoms: Group I = 30 patients with active angina, Group II= 38 patients with history of CAD but no symptoms, and Group III= 40 patients with no 
symptoms and no CAD. Peripheral blood was taken and sent in special kits for determination of 23-gene expression and determination of CS.
Results:  The mean CS in Group I , II and III were 36 ± 5 , 24 ± 4 and 22 ± 3. This difference was significant between Group I and II and I and III ( 
p<0.04). It was not significant between Group II and III.
Conclusions:  In patients with angina and CAD the CS is elevated. In those with “dormant” CAD and no CAD the CS is low. A high CS would 
therefore warrant further evaluation although a low CS would not exclude prior history of CAD.
